EP3055286A4 - 4-méthylsulfonyl-2-butènenitrile et son utilisation pharmaceutique - Google Patents

4-méthylsulfonyl-2-butènenitrile et son utilisation pharmaceutique Download PDF

Info

Publication number
EP3055286A4
EP3055286A4 EP14852179.2A EP14852179A EP3055286A4 EP 3055286 A4 EP3055286 A4 EP 3055286A4 EP 14852179 A EP14852179 A EP 14852179A EP 3055286 A4 EP3055286 A4 EP 3055286A4
Authority
EP
European Patent Office
Prior art keywords
butenenitrile
methylsulfonyl
pharmaceutical use
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP14852179.2A
Other languages
German (de)
English (en)
Other versions
EP3055286A1 (fr
Inventor
Joseph P. St. Laurent
Gerald S. Jones
David M. Bresse
Scott A. Goodrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olatec Therapeutics LLC
Original Assignee
Olatec Therapeutics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olatec Therapeutics LLC filed Critical Olatec Therapeutics LLC
Publication of EP3055286A1 publication Critical patent/EP3055286A1/fr
Publication of EP3055286A4 publication Critical patent/EP3055286A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP14852179.2A 2013-10-07 2014-10-01 4-méthylsulfonyl-2-butènenitrile et son utilisation pharmaceutique Withdrawn EP3055286A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361887776P 2013-10-07 2013-10-07
PCT/US2014/058685 WO2015054008A1 (fr) 2013-10-07 2014-10-01 4-méthylsulfonyl-2-butènenitrile et son utilisation pharmaceutique

Publications (2)

Publication Number Publication Date
EP3055286A1 EP3055286A1 (fr) 2016-08-17
EP3055286A4 true EP3055286A4 (fr) 2017-05-24

Family

ID=52813515

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14852179.2A Withdrawn EP3055286A4 (fr) 2013-10-07 2014-10-01 4-méthylsulfonyl-2-butènenitrile et son utilisation pharmaceutique

Country Status (4)

Country Link
EP (1) EP3055286A4 (fr)
JP (1) JP6426746B2 (fr)
CN (1) CN105683158A (fr)
WO (1) WO2015054008A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017504380A (ja) * 2013-12-20 2017-02-09 ザ プロクター アンド ギャンブル カンパニー 形状及びフィット感を改善したおむつ

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014043144A1 (fr) * 2012-09-11 2014-03-20 Olatec Industries Llc Méthodes de traitement de l'inflammation et de la douleur

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444175A (en) * 1966-11-09 1969-05-13 Merck & Co Inc Certain picolylmethyl sulfones
WO2012082718A2 (fr) * 2010-12-15 2012-06-21 Olatec Industries Llc 3-méthanesulfonylpropionitrile pour le traitement d'une inflammation et de la douleur
EP2819995B1 (fr) * 2012-02-27 2017-02-01 Olatec Therapeutics LLC Processus de préparation de 3-méthylsulfonylpropionitrile

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014043144A1 (fr) * 2012-09-11 2014-03-20 Olatec Industries Llc Méthodes de traitement de l'inflammation et de la douleur

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2015054008A1 *

Also Published As

Publication number Publication date
JP2016539179A (ja) 2016-12-15
WO2015054008A1 (fr) 2015-04-16
EP3055286A1 (fr) 2016-08-17
CN105683158A (zh) 2016-06-15
JP6426746B2 (ja) 2018-11-21

Similar Documents

Publication Publication Date Title
EP3708210B8 (fr) Interface pour patient et ses aspects
EP3074073A4 (fr) Dispositif pour médicament
EP3060561A4 (fr) Formulations de strigolactone et leurs utilisations
EP3030566A4 (fr) Composés d'aza-pyridone et leurs utilisations
EP3087059A4 (fr) Indazoles et leur utilisation
EP2968307A4 (fr) Dérivés de carboxamide et leur utilisation
EP3087057A4 (fr) Morphinanes à cycle contracté et leur utilisation
EP3083606A4 (fr) Pyrimidines et leur utilisation
EP3038458A4 (fr) Unité de semis et ses utilisations
EP2999482A4 (fr) Promédicaments et médicaments
EP3075847A4 (fr) Transaminase et utilisation associée
EP2983681A4 (fr) Compositions thérapeutiques et leurs utilisations
EP3068443A4 (fr) Groupes de liaison à résidualisation et leurs applications
EP3017225A4 (fr) Support et utilisation
EP3048108A4 (fr) Dérivé thiénopipéridine et son utilisation
EP3081644A4 (fr) Lipase modifiée et son utilisation
EP3042689A4 (fr) Seringue et ensemble de seringue
EP3064491A4 (fr) Dérivé de sulfonamide et son utilisation médicinale
EP3041891A4 (fr) Matériaux et procédés
EP3068388A4 (fr) Composés neuroprotecteurs et leur utilisation
HK1219691A1 (zh) 醫藥組成物及其用途
EP2991949A4 (fr) Matières polycarbosiloxanes et procédés s'y rapportant
EP2968274A4 (fr) Dérivés de méropénème et leurs utilisations
IL240177A (en) Chromium-6-Iloxy-cycloalkanes are conserved and used as drugs
WO2014202624A9 (fr) Gène de rasamsonia et son utilisation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160429

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170426

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 317/44 20060101AFI20170420BHEP

Ipc: A61P 29/00 20060101ALI20170420BHEP

Ipc: A61K 31/275 20060101ALI20170420BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20171123